Eli Lilly and Company Logo

Eli Lilly and Company (LLY)

XETR

Currency in EUR
1,075.80
+43.60 (+4.22%)

Closed

Oct 7, 2026

Day's Range

1,033.20
1,075.80

52 wk Range

662.90
1,107.00

Overview - LLY - Eli Lilly and Company

Key Statistics

Valuation

Enterprise Value

848.14B

P/E (Trailing)

‪38.46‬

P/E (Forward)

‪143.49‬

PEG Ratio

‪1.46‬

Price / Sales (TTM)

‪11.38‬

Price / Book

‪30.94‬

EV / EBITDA

‪22.84‬

Profitability

Gross Margin

‪85.77%‬

Profit Margin

‪33.52%‬

Operating Margin

‪54.22%‬

Return on Assets

‪20.35%‬

Return on Equity

‪102.28%‬

Ownership

Shares Outstanding

891.50M

Float

888.95M

Held by Insiders

‪0.15%‬

Held by Institutions

‪85.30%‬

Price stats

Beta

‪0.50‬

50-Day Avg

‪1,022.44‬

200-Day Avg

‪927.58‬

Dividends

Payout Ratio

‪21.69%‬

Frequency

Quarterly

News Teaser - LLY - Eli Lilly and Company

News & Analysis

View all news

Market Cap - LLY - Eli Lilly and Company

Peers - LLY - Eli Lilly and Company

Peer Comparison

Compared with companies in Drug Manufacturers - General listed on XETR.

Profile Summary - LLY - Eli Lilly and Company

About

Eli Lilly and Company is a global medicine company focused on discovering, developing, manufacturing, and marketing human pharmaceutical products. Eli Lilly and Company operates across major therapeutic areas including diabetes, obesity, oncology, immunology, neuroscience, and cardiovascular care, serving patients,…

SectorHealthcare
IndustryDrug Manufacturers - General
Employees50K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.